Ampacet to invest in controlled environment rooms for production of medical grade masterbatches

Ampacet, a global masterbatch leader, is proud to announce its investment in controlled environment rooms at its newly opened production plant in Brembate (BG), Italy.
“There is significant global impact from aging populations, not only in terms of individual health risks but in terms of societal pressures and issues. Ampacet is committed to supporting society by supplying advanced materials to the pharma and healthcare industry,” said Marcello Bergamo, Ampacet Europe Managing Director.
“The Ampacet ProVital+ masterbatch range, specifically designed for medical and pharmaceutical applications, was introduced in 2021. To serve critical applications and respond to the high industry standards, Ampacet is investing in dedicated clean manufacturing areas to ensure that the ProVital+ range is produced according to good manufacturing practices in a safe environment,” he added.